----
Current ValuationThe current P/E ratio is 71.81, within the reasonable range, cheaper than 68.71% of the time in the past 5 years, and the industry ranks 28/84, the industry Median 19.89.
71.81xP/E
¥17.27Stock price
¥0.24Earnings per share
71.81xP/E
Stock price¥17.27Earnings per share¥0.24
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 76.83x
- Typical range
- 67.15x–114.24x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 19.89x
023466992
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 19.89x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
301047SZSino Biological | 79.77x | 37.49% | ¥14.29B |
600645SHVCANBIO | 71.81x | -- | ¥8.08B |
688366SHHAOHAI BIOTEC | 60.23x | -- | ¥6.58B |
688163SHSHANGHAI SERUM BIO-TECHNOLOGY | 64.95x | -- | ¥3.29B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
